CENOVIS MEGA B

Land: Australien

Sprache: Englisch

Quelle: Department of Health (Therapeutic Goods Administration)

Wirkstoff:

thiamine nitrate, Quantity: 50 mg; folic acid, Quantity: 200 microgram; riboflavine, Quantity: 25 mg; nicotinamide, Quantity: 50 mg; Biotin, Quantity: 50 microgram; inositol, Quantity: 50 microgram; choline bitartrate, Quantity: 50 microgram; calcium pantothenate, Quantity: 50 mg (Equivalent: pantothenic acid, Qty 46 mg); ascorbic acid, Quantity: 100 mg; cyanocobalamin, Quantity: 50 microgram; pyridoxine hydrochloride, Quantity: 50 mg (Equivalent: pyridoxine, Qty 41.13 mg)

Verfügbar ab:

Sanofi-Aventis Healthcare Pty Ltd T/A Sanofi Consumer Healthcare

INN (Internationale Bezeichnung):

Ascorbic acid,Biotin,Calcium pantothenate,Choline bitartrate,Cyanocobalamin,Folic acid,Inositol,Nicotinamide,pyridoxine hydrochl

Darreichungsform:

Tablet, film coated

Zusammensetzung:

Excipient Ingredients: magnesium stearate; colloidal anhydrous silica; silicon dioxide; microcrystalline cellulose; iron oxide red; macrogol 6000; hypromellose; crospovidone; purified talc; vanillin; iron oxide black; calcium hydrogen phosphate dihydrate; calcium lactate pentahydrate

Verabreichungsweg:

Oral

Anwendungsgebiete:

Antioxidant/Reduce free radicals formed in the body ; Maintain/support energy levels ; Helps convert (state food) into energy ; Maintain/support energy production ; Maintain/support general health and wellbeing ; Maintain/support healthy immune system function ; Helps prevent dietary (state vitamin/mineral/nutrient) deficiency ; Maintain/support (state vitamin/mineral) within normal range ; Maintain/support nervous system function

Produktbesonderheiten:

Visual Identification: ;

Berechtigungsstatus:

Licence status A

Berechtigungsdatum:

2004-10-21